Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
LMNR Stock Summary
Top 10 Correlated ETFs
LMNR
In the News
Limoneira Company (LMNR) Q1 2024 Earnings Call Transcript
Limoneira Company (NASDAQ:LMNR ) Q1 2024 Earnings Conference Call March 7, 2024 4:30 PM ET Company Participants John Mills - IR, ICR Harold Edwards - President & CEO Mark Palamountain - CFO Conference Call Participants Ben Bienvenu - Stephens Benjamin Klieve - Lake Street Capital Markets Rajiv Sharma - B. Riley Securities Operator Greetings, and welcome to the Limoneira First Quarter 2024 Financial Results Conference Call.
Limoneira (LMNR) Reports Q1 Loss, Tops Revenue Estimates
Limoneira (LMNR) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.53 per share a year ago.
7 Cheap Dividend Stocks to Grab for Under $20 This March
Passive income usually denotes high-priced blue chips but certain cheap dividend stocks to buy can offer the best of all worlds. Yes, they're risky and you don't want to put all your eggs in one basket.
Limoneira to Announce First Quarter 2024 Financial Results on March 7, 2024
SANTA PAULA, Calif.--(BUSINESS WIRE)--Limoneira Company (the “Company” or “Limoneira”) (Nasdaq: LMNR), a diversified citrus growing, packing, selling and marketing company with related agribusiness activities and real estate development operations, announced today it will release financial results for the first quarter ended January 31, 2024, on Thursday, March 7, 2024, after the market close. The Company will host a conference call to discuss its financial results on March 7, 2024, at 1:30 pm.
Limoneira to Present at the 26th Annual ICR Conference
SANTA PAULA, Calif.--(BUSINESS WIRE)--Limoneira Company (the “Company” or “Limoneira”) (Nasdaq: LMNR), a diversified citrus growing, packing, selling and marketing company with related agribusiness activities and real estate development operations, today announced that Harold Edwards, the Company's Chief Executive Officer, and Mark Palamountain, the Company's Chief Financial Officer, will be presenting at the 26th Annual ICR Conference, to be held January 8-10, 2024, at the JW Marriot Orlando G.
Limoneira Company (LMNR) Q4 2023 Earnings Call Transcript
Limoneira Company (LMNR) Q4 2023 Earnings Call Transcript
Limoneira (LMNR) Reports Q4 Loss, Tops Revenue Estimates
Limoneira (LMNR) came out with a quarterly loss of $0.15 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.32 per share a year ago.
Limoneira Company (LMNR) Q3 2023 Earnings Call Transcript
Limoneira Company (NASDAQ:LMNR ) Q3 2023 Earnings Conference Call September 7, 2023 4:30 PM ET Company Participants John Mills - Senior Managing Director, ICR Harold Edwards - President, CEO & Director Mark Palamountain - CFO & Treasurer Conference Call Participants Ben Bienvenu - Stephens Ben Klieve - Lake Street Capital Markets Vincent Anderson - Stifel Raj Sharma - B. Riley Operator Greetings, and welcome to Limoneira's Third Quarter Fiscal Year 2023 Financial Results Conference Call.
Limoneira (LMNR) Q3 Earnings Lag Estimates
Limoneira (LMNR) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.41 per share a year ago.
4 Stocks to Watch as the Agriculture Operations Industry Recovers
Agriculture - Operations industry is well-poised to gain on solid product portfolios and innovation in the near term, offset by impacts of raw material and commodity price inflation. Companies like ADM, AGRO, DOLE and LMNR stand to gain.
LMNR Financial details
LMNR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-10-31
Metric | History | 2019-10-31 | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 9.76 | 9.32 | 9.6 | 10.54 | 10.22 | |
Net income per share | -0.31 | -1.02 | -0.23 | -0.03 | 0.53 | |
Operating cash flow per share | 0.08 | -0.64 | 0.56 | 0.85 | -0.9 | |
Free cash flow per share | -0.85 | -1.24 | -0.01 | 0.27 | -1.49 | |
Cash per share | 0.04 | 0.03 | 0.03 | 1.02 | 0.21 | |
Book value per share | 12.37 | 10.92 | 10.83 | 10.29 | 10.75 | |
Tangible book value per share | 12.43 | 10.97 | 10.95 | 10.45 | 10.93 | |
Share holders equity per share | 12.37 | 10.92 | 10.83 | 10.29 | 10.75 | |
Interest debt per share | 6.33 | 7.24 | 7.77 | 6.17 | 2.36 | |
Market cap | 332.12M | 244.32M | 280.98M | 208.93M | 251.55M | |
Enterprise value | 440.42M | 369.67M | 413.37M | 313.88M | 288.92M | |
P/E ratio | -60.76 | -13.62 | -72.1 | -440.78 | 26.76 | |
Price to sales ratio | 1.94 | 1.48 | 1.69 | 1.13 | 1.4 | |
POCF ratio | 243.31 | -21.59 | 29.25 | 14.09 | -15.85 | |
PFCF ratio | -22.29 | -11.15 | -1.23K | 43.86 | -9.61 | |
P/B Ratio | 1.53 | 1.27 | 1.5 | 1.16 | 1.33 | |
PTB ratio | 1.53 | 1.27 | 1.5 | 1.16 | 1.33 | |
EV to sales | 2.57 | 2.25 | 2.49 | 1.7 | 1.61 | |
Enterprise value over EBITDA | -79.57 | -21.02 | -161.92 | -168.75 | -16.74 | |
EV to operating cash flow | 322.65 | -32.66 | 43.04 | 21.17 | -18.21 | |
EV to free cash flow | -29.56 | -16.87 | -1.81K | 65.89 | -11.04 | |
Earnings yield | -0.02 | -0.07 | -0.01 | 0 | 0.04 | |
Free cash flow yield | -0.04 | -0.09 | 0 | 0.02 | -0.1 | |
Debt to equity | 0.5 | 0.65 | 0.71 | 0.59 | 0.22 | |
Debt to assets | 0.27 | 0.32 | 0.34 | 0.29 | 0.14 | |
Net debt to EBITDA | -19.57 | -7.13 | -51.86 | -56.43 | -2.17 | |
Current ratio | 1.11 | 1.35 | 1.19 | 0.96 | 0.91 | |
Interest coverage | -3.08 | -9.04 | -4.15 | -1 | 21.83 | |
Income quality | -0.25 | 0.63 | -2.46 | -31.29 | -1.74 | |
Dividend Yield | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | |
Payout ratio | -1.07 | -0.33 | -1.49 | -12.27 | 0.63 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.04 | 0.03 | 0.03 | 0.02 | 0.03 | |
Capex to operating cash flow | -11.92 | 0.94 | -1.02 | -0.68 | 0.65 | |
Capex to revenue | -0.09 | -0.06 | -0.06 | -0.05 | -0.06 | |
Capex to depreciation | -1.88 | -1.05 | -1 | -1.03 | -1.2 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | |
Graham number | 9.31 | 15.79 | 7.41 | 2.5 | 11.37 | |
ROIC | -0.02 | -0.04 | -0.02 | 0.01 | 0.03 | |
Return on tangible assets | -0.01 | -0.05 | -0.01 | 0 | 0.03 | |
Graham Net | -8.35 | -8.99 | -9.83 | -7.87 | -4.58 | |
Working capital | 3.41M | 11.06M | 6.77M | -1.74M | -3.13M | |
Tangible asset value | 218.25M | 193.73M | 189.39M | 183.04M | 192.33M | |
Net current asset value | -132.3M | -140.51M | -150.94M | -139.12M | -70.49M | |
Invested capital | 0.5 | 0.65 | 0.71 | 0.59 | 0.22 | |
Average receivables | 16.79M | 21.77M | 23.95M | 21.49M | 19.11M | |
Average payables | 17.85M | 16.72M | 16.65M | 20.37M | 20.46M | |
Average inventory | 9.66M | 11.12M | 10.34M | 11.41M | 8.79M | |
Days sales outstanding | 40.63 | 54.27 | 51.53 | 38.63 | 37.88 | |
Days payables outstanding | 45.33 | 31.5 | 46.18 | 47.32 | 41 | |
Days of inventory on hand | 26.98 | 24.03 | 23.93 | 28.28 | 10.06 | |
Receivables turnover | 8.98 | 6.73 | 7.08 | 9.45 | 9.63 | |
Payables turnover | 8.05 | 11.59 | 7.9 | 7.71 | 8.9 | |
Inventory turnover | 13.53 | 15.19 | 15.25 | 12.91 | 36.26 | |
ROE | -0.03 | -0.09 | -0.02 | 0 | 0.05 | |
Capex per share | -0.93 | -0.6 | -0.57 | -0.57 | -0.59 |
Quarterly Fundamentals Overview
Last date of statement is 2024-01-31 for Q1
Metric | History | 2023-01-31 | 2023-04-30 | 2023-07-31 | 2023-10-31 | 2024-01-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.16 | 2.73 | 2.98 | 2.35 | 2.25 | |
Net income per share | 0.89 | -0.09 | -0.07 | -0.2 | -0.2 | |
Operating cash flow per share | -1.21 | 0.16 | 0.33 | -0.19 | -0.58 | |
Free cash flow per share | -1.33 | -0.03 | 0.13 | -0.26 | -0.71 | |
Cash per share | 0.71 | 0.56 | 0.62 | 0.21 | 0.03 | |
Book value per share | 11.35 | 11.21 | 11.06 | 10.74 | 10.44 | |
Tangible book value per share | 11.49 | 11.36 | 11.22 | 10.91 | 10.61 | |
Share holders equity per share | 11.35 | 11.21 | 11.06 | 10.74 | 10.44 | |
Interest debt per share | 2.42 | 2.4 | 2.35 | 2.33 | 3.1 | |
Market cap | 230.73M | 301.44M | 273.48M | 251.82M | 319.75M | |
Enterprise value | 259.64M | 332.89M | 303.64M | 289.2M | 375.6M | |
P/E ratio | 3.69 | -46.23 | -58.79 | -18.22 | -22.13 | |
Price to sales ratio | 6.09 | 6.27 | 5.21 | 6.08 | 8.05 | |
POCF ratio | -10.89 | 109.73 | 46.71 | -76.73 | -31.32 | |
PFCF ratio | -9.89 | -580.8 | 118.29 | -54.42 | -25.68 | |
P/B Ratio | 1.16 | 1.53 | 1.4 | 1.33 | 1.74 | |
PTB ratio | 1.16 | 1.53 | 1.4 | 1.33 | 1.74 | |
EV to sales | 6.85 | 6.93 | 5.78 | 6.98 | 9.45 | |
Enterprise value over EBITDA | -16.02 | 28.06 | 1.92K | -65.73 | -64.18 | |
EV to operating cash flow | -12.25 | 121.18 | 51.86 | -88.12 | -36.79 | |
EV to free cash flow | -11.12 | -641.4 | 131.33 | -62.5 | -30.17 | |
Earnings yield | 0.07 | -0.01 | 0 | -0.01 | -0.01 | |
Free cash flow yield | -0.1 | 0 | 0.01 | -0.02 | -0.04 | |
Debt to equity | 0.21 | 0.21 | 0.21 | 0.22 | 0.3 | |
Debt to assets | 0.13 | 0.13 | 0.13 | 0.14 | 0.18 | |
Net debt to EBITDA | -1.78 | 2.65 | 190.91 | -8.5 | -9.54 | |
Current ratio | 1.08 | 1.18 | 1.15 | 0.91 | 0.92 | |
Interest coverage | 22.09 | 9.86 | -6.43 | -125.84 | -30.08 | |
Income quality | -1.36 | -1.69 | -4.68 | 0.93 | 2.83 | |
Dividend Yield | 0.01 | 0 | 0.01 | 0.01 | 0 | |
Payout ratio | 0.09 | -0.9 | -1.27 | -0.43 | -0.41 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Capex to operating cash flow | 0.1 | -1.19 | -0.61 | 0.41 | 0.22 | |
Capex to revenue | -0.06 | -0.07 | -0.07 | -0.03 | -0.06 | |
Capex to depreciation | -0.88 | -1.6 | -1.75 | -0.65 | -1.09 | |
Stock based compensation to revenue | 0.03 | 0.02 | 0.01 | 0.03 | 0.02 | |
Graham number | 15.07 | 4.83 | 4.05 | 6.88 | 6.94 | |
ROIC | 0.07 | 0.03 | 0 | -0.03 | -0.02 | |
Return on tangible assets | 0.05 | -0.01 | 0 | -0.01 | -0.01 | |
Graham Net | -4.46 | -4.47 | -4.22 | -4.58 | -5.01 | |
Working capital | 3.18M | 6.97M | 5.74M | -3.13M | -2.35M | |
Tangible asset value | 201.92M | 199.89M | 197.68M | 192.33M | 187.07M | |
Net current asset value | -68.37M | -62.34M | -63.43M | -70.49M | -75.98M | |
Invested capital | 0.21 | 0.21 | 0.21 | 0.22 | 0.3 | |
Average receivables | 20.32M | 21.05M | 22.15M | 20.98M | 19.89M | |
Average payables | 17.75M | 15.29M | 16.54M | 18.06M | 18.29M | |
Average inventory | 10.01M | 7.03M | 7.05M | 6.04M | 2.4M | |
Days sales outstanding | 50.09 | 39.34 | 39.94 | 40.56 | 47.79 | |
Days payables outstanding | 29.85 | 37.85 | 31.18 | 39.73 | 37.81 | |
Days of inventory on hand | 15.33 | 15.65 | 13.68 | 9.75 | 0 | |
Receivables turnover | 1.8 | 2.29 | 2.25 | 2.22 | 1.88 | |
Payables turnover | 3.01 | 2.38 | 2.89 | 2.27 | 2.38 | |
Inventory turnover | 5.87 | 5.75 | 6.58 | 9.23 | 0 | |
ROE | 0.08 | -0.01 | -0.01 | -0.02 | -0.02 | |
Capex per share | -0.12 | -0.19 | -0.2 | -0.08 | -0.13 |
LMNR Frequently Asked Questions
What is Limoneira Company stock symbol ?
Limoneira Company is a US stock , located in Santa paula of Ca and trading under the symbol LMNR
Is Limoneira Company buy or a sell ?
1 stock analysts have 1 predictions with a medium analyst target price of $17. The lowest prediction is $17 and the highest is $17
What is LMNR stock prediction ?
What is Limoneira Company stock quote today ?
Limoneira Company stock price is $19.59 today.
Is Limoneira Company stock public?
Yes, Limoneira Company is a publicly traded company.